Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

KRYS

Krystal Biotech Inc

Jun 12 • 04:00PM ET

140.33

Dollar change +0.71
Percentage change 0.51	%

Healthcare • Biotechnology • USA • NASD

Peers: AMGN BIIB REGN VRTX BMRN INCY NBIX SRPT AXSM QURE

| Held by: IJR VTI VB IWM VXF VBK XBI IJT SPSM IWO

Scroll to Statements

Index	RUT	P/E	33.79	EPS (ttm)	4.15	Insider Own	14.14%	Shs Outstand	28.90M	Perf Week	5.81%
Market Cap	4.06B	Forward P/E	16.09	EPS next Y	8.72	Insider Trans	-4.68%	Shs Float	24.81M	Perf Month	4.31%
Income	123.96M	PEG	0.55	EPS next Q	1.30	Inst Own	93.09%	Short Float	11.77%	Perf Quarter	-20.88%
Sales	333.45M	P/S	12.16	EPS this Y	99.88%	Inst Trans	-1.28%	Short Ratio	8.49	Perf Half Y	-23.90%
Book/sh	34.07	P/B	4.12	EPS next Y	45.41%	ROA	12.86%	Short Interest	2.92M	Perf Year	-20.64%
Cash/sh	21.35	P/C	6.57	EPS next 5Y	61.67%	ROE	13.90%	52W Range	122.80 - 219.34	Perf YTD	-10.42%
Dividend Est.	-	P/FCF	31.36	EPS past 5Y	-	ROIC	12.48%	52W High	-36.02%	Beta	0.67
Dividend TTM	-	Quick Ratio	9.27	Sales past 5Y	-	Gross Margin	91.19%	52W Low	14.28%	ATR (14)	5.39
Dividend Ex-Date	-	Current Ratio	9.65	EPS Y/Y TTM	118.34%	Oper. Margin	40.05%	RSI (14)	54.24	Volatility	0.93% 1.79%
Employees	275	Debt/Eq	0.01	Sales Y/Y TTM	247.53%	Profit Margin	37.18%	Recom	1.18	Target Price	205.20
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	3661.64%	Payout	0.00%	Rel Volume	1.26	Prev Close	139.62
Sales Surprise	-8.34%	EPS Surprise	-15.89%	Sales Q/Q	94.88%	Earnings	May 06 BMO	Avg Volume	344.03K	Price	140.33
SMA20	7.32%	SMA50	-5.50%	SMA200	-16.87%	Trades		Volume	429,263	Change	0.51%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-05-25	Initiated	Jefferies	Buy	$245
Aug-06-24	Downgrade	Citigroup	Buy → Neutral	$195 → $204
Nov-20-23	Initiated	Goldman	Buy	$160
Oct-24-23	Initiated	Cantor Fitzgerald	Overweight	$100
Oct-12-23	Initiated	Citigroup	Buy	$160
Sep-07-23	Initiated	Berenberg	Buy	$154
Apr-18-23	Initiated	Stifel	Buy	$102
Feb-28-23	Upgrade	Goldman	Neutral → Buy	$79 → $124
Aug-25-22	Downgrade	Goldman	Buy → Neutral	$74
Jan-18-22	Initiated	BofA Securities	Buy	$110
Jul-20-21	Upgrade	Goldman	Neutral → Buy	$73 → $90
Sep-18-20	Initiated	B. Riley FBR	Buy	$100
Jun-04-20	Initiated	Evercore ISI	Outperform	$90
Sep-24-19	Initiated	Goldman	Neutral	$60
Aug-06-19	Reiterated	H.C. Wainwright	Buy	$56 → $59
Jun-24-19	Reiterated	H.C. Wainwright	Buy	$38 → $56
Jun-24-19	Reiterated	Chardan Capital Markets	Buy	$57.50 → $75
May-30-19	Initiated	Guggenheim	Buy
Sep-11-18	Initiated	Cantor Fitzgerald	Overweight	$28

Show Previous Ratings

Jun-05-25 11:30AM	Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report? (Zacks)
Jun-03-25 08:00AM	Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
Jun-02-25 11:04AM	Implied Volatility Surging for Krystal Biotech Stock Options (Zacks)
May-14-25 08:30AM	Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn't Ignore (MarketBeat)
May-10-25 11:55AM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
10:30AM	Loading…
May-09-25 10:30AM	Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain (Insider Monkey)
May-07-25 08:00AM	Krystal Biotech to Present at BofA Securities 2025 Health Care Conference (GlobeNewswire)
03:08AM	Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
May-06-25 01:37PM	Krystal Biotech Q1 Earnings and Sales Miss Estimates, Stock Down (Zacks) -14.06%
09:15AM	Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates (Zacks)
08:00AM	Krystal Biotech Announces First Quarter 2025 Financial and Operating Results (GlobeNewswire)
May-05-25 09:27AM	Krystal Biotech Inc (KRYS) Q1 2025 Earnings Report Preview: What to Look For (GuruFocus.com)
May-01-25 10:01AM	Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline (Zacks)
Apr-29-25 10:01AM	Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy? (Zacks)
06:24AM	Abeona cell therapy approved by FDA for rare skin condition (BioPharma Dive)
07:00AM	Loading…
Apr-28-25 07:00AM	Krystal Biotech Announces European Commission Approval of VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa (GlobeNewswire)
Apr-24-25 08:00AM	Krystal Biotech to Present at Upcoming Scientific Conferences (GlobeNewswire)
Apr-21-25 10:00AM	Pz-Cel Has Massive Potential For RDEB Patients (Seeking Alpha)
09:22AM	Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria (Zacks)
Apr-17-25 08:00AM	Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-16-25 11:47AM	Sanofi Advances Mid-to-Late-Stage Pipeline in Respiratory Indications (Zacks)
Apr-15-25 10:42AM	Fate Therapeutics' Lupus Candidate FT819 Gets FDA RMAT Tag (Zacks)
09:18AM	Ironwood Shares Tank on Regulatory Update for Apraglutide (Zacks)
Apr-14-25 09:51AM	Roche Gets Nod for Expanded Use of Columvi in Lymphoma in Europe (Zacks)
Apr-12-25 11:39AM	Abeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher (Seeking Alpha)
Apr-11-25 11:49AM	Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate (Zacks)
Apr-10-25 11:50AM	TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why (Zacks)
11:05AM	TPST to Evaluate Strategic Options for Pipeline Studies, Stock Up (Zacks)
Apr-08-25 09:40AM	Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-07-25 04:30PM	Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer (GlobeNewswire)
01:22PM	Loading…
01:22PM	5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025 (Zacks)
10:53AM	AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs (Zacks)
Apr-06-25 08:38AM	Krystal Biotech: Some Uncertainty, Some Value (Seeking Alpha)
Apr-04-25 01:10PM	AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication (Zacks)
Apr-03-25 11:27AM	SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases (Zacks)
Apr-02-25 11:29AM	AXSM Stock Down on Top-Line Data From Depression Study on Solriamfetol (Zacks)
09:33AM	Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680 (Zacks)
Apr-01-25 10:55AM	VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates (Zacks)
Mar-28-25 11:30AM	Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound? (Zacks)
09:26AM	BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance (Zacks)
Mar-27-25 11:36AM	NTLA Genome-Editing Therapy Gets FDA's RMAT Tag for New Indication (Zacks)
Mar-26-25 11:53AM	Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag (Zacks)
11:51AM	AXSM Stock Down Despite ADHD Study Meeting Primary Endpoint (Zacks)
Mar-25-25 12:44PM	Will Alkermes' Proprietary Drugs Aid Growth Amid Stiff Competition? (Zacks)
Mar-24-25 02:36PM	EMA Accepts GSK's Filing for Expanded Use of Nucala in COPD (Zacks)
08:30AM	Krystal Biotech: Preparing To Chase Following Positive CHMP Opinion For VYJUVEK (SeekingAlpha)
Mar-21-25 11:30AM	Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-17-25 09:50AM	Here's Why Krystal Biotech, Inc. (KRYS) is a Strong Momentum Stock (Zacks)
Feb-28-25 07:40AM	Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa (GlobeNewswire)
Feb-26-25 08:00AM	Krystal Biotech to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-24-25 12:20PM	Why Krystal Biotech (KRYS) Might be Well Poised for a Surge (Zacks)
09:50AM	Why Krystal Biotech, Inc. (KRYS) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-21-25 12:00PM	Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-20-25 02:06AM	Krystal Biotech Inc (KRYS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
12:37AM	Q4 2024 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-19-25 07:00AM	Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire) +12.43%
04:35AM	Krystal Biotech Inc (KRYS) Q4 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Feb-06-25 08:00AM	Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025 (GlobeNewswire)
Jan-24-25 09:36AM	Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock? (Zacks)
Jan-14-25 08:00AM	Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer (GlobeNewswire) -5.10%
Dec-18-24 08:00AM	Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer (GlobeNewswire) -7.34%
Dec-13-24 08:20AM	Krystal Biotech announces initial update for KB408, KB407 (TipRanks) -5.63%
Dec-12-24 08:00AM	Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels (GlobeNewswire) -7.33%
Dec-09-24 04:15PM	Krystal Biotech Provides Update on EMA's Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa (GlobeNewswire)
Dec-04-24 11:30AM	Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report? (Zacks)
Nov-27-24 07:00AM	Krystal Biotech to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-12-24 07:00AM	Krystal Biotech to Present at Stifel 2024 Healthcare Conference (GlobeNewswire)
Nov-06-24 07:00AM	Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference (GlobeNewswire)
Nov-05-24 02:52AM	Q3 2024 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents)
02:04AM	Krystal Biotech Inc (KRYS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-04-24 09:10AM	Krystal Biotech, Inc. (KRYS) Beats Q3 Earnings and Revenue Estimates (Zacks)
08:00AM	Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-01-24 09:02AM	Earnings To Watch: Krystal Biotech Inc (KRYS) Reports Q3 2024 Results (GuruFocus.com)
08:30AM	Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock? (Zacks)
Oct-28-24 10:01AM	Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth (Zacks)
07:00AM	Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024 (GlobeNewswire)
Oct-18-24 12:00PM	All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to Buy (Zacks)
Oct-16-24 03:02PM	State Street Corp's Strategic Acquisition in Krystal Biotech Inc (GuruFocus.com)
Sep-21-24 10:50AM	Krystal Biotech, Inc. (KRYS): Promising Pipeline or Risky Gamble? (Insider Monkey)
Sep-18-24 01:12PM	Biotech Stock Offers A Buy Point After 256% Average Yearly Gain (Investor's Business Daily)
Sep-13-24 07:00AM	Krystal Biotech to Present at 2024 Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-24 07:00AM	Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Sep-03-24 12:20PM	Surging Earnings Estimates Signal Upside for Krystal Biotech (KRYS) Stock (Zacks)
Aug-28-24 07:00AM	Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Decollete (GlobeNewswire)
07:00AM	Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the D collet (GlobeNewswire)
Aug-07-24 12:00PM	Krystal Biotech (KRYS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Aug-06-24 03:48AM	Q2 2024 Krystal Biotech Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-05-24 12:59PM	Apple, Krystal Biotech fall; Tyson Foods, Kellanova rise, Monday, 8/5/2024 (Associated Press Finance) -5.85%
12:53PM	KRYS Stock Earnings: Krystal Biotech Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
09:15AM	Krystal Biotech, Inc. (KRYS) Q2 Earnings and Revenues Top Estimates (Zacks)
08:00AM	Krystal Biotech Announces Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-01-24 08:00AM	After A 65% Run This Year, Krystal Biotech Has Plenty More In The Tank (Investor's Business Daily)
Jul-26-24 08:00AM	Krystal Biotech to Report Second Quarter 2024 Financial Results on August 5, 2024 (GlobeNewswire)
Jul-18-24 08:50AM	Krystal Biotech (KRYS) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Jun-25-24 06:33PM	Why Is Augmedix, Inc. (AUGX) the Most Popular AI Penny Stock Under $1? (Insider Monkey)
Jun-21-24 12:16AM	Krystal Biotech (KRYS) Surged as it Beat the Streat Estimates with Wide Margin (Insider Monkey)
Jun-11-24 02:45PM	Krystal Biotech Stock Sees RS Rating Jump To 91 (Investor's Business Daily)
Jun-07-24 06:09PM	KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +7.55%
Jun-05-24 07:00AM	Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
Jun-03-24 04:30PM	Is Krystal Biotech, Inc. (NASDAQ:KRYS) the Premier Gene Therapy Stock for Your Portfolio? (Insider Monkey)

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Krishnan Suma	President, R&D	Mar 13 '25	Sale	177.79	25,000	4,444,763	1,533,056	Mar 13 06:06 PM
Krishnan Suma	President, R&D	Mar 13 '25	Sale	177.79	25,000	4,444,761	1,463,711	Mar 13 06:06 PM
Krishnan Krish S	President and CEO	Mar 13 '25	Sale	177.79	25,000	4,444,763	1,533,056	Mar 13 06:04 PM
Krishnan Krish S	President and CEO	Mar 13 '25	Sale	177.79	25,000	4,444,761	1,463,711	Mar 13 06:04 PM
SUMA KRISHNAN	Director	Mar 13 '25	Proposed Sale	178.39	25,000	4,459,750		Mar 13 04:26 PM
KRISH S KRISHNAN	Director	Mar 13 '25	Proposed Sale	178.39	25,000	4,459,750		Mar 13 04:25 PM
ROMANO KATHRYN	Chief Accounting Officer	Feb 28 '25	Option Exercise	0.00	12,500	0	22,789	Feb 28 07:01 PM
ROMANO KATHRYN	Chief Accounting Officer	Feb 27 '25	Sale	175.22	750	131,415	12,604	Feb 28 07:01 PM
Krishnan Suma	President, R&D	Feb 28 '25	Option Exercise	0.00	47,500	0	1,574,926	Feb 28 07:00 PM
Krishnan Suma	President, R&D	Feb 28 '25	Option Exercise	0.00	30,000	0	1,499,125	Feb 28 07:00 PM
Krishnan Krish S	President and CEO	Feb 28 '25	Option Exercise	0.00	30,000	0	1,502,411	Feb 28 06:58 PM
Krishnan Krish S	President and CEO	Feb 28 '25	Option Exercise	0.00	47,500	0	1,570,205	Feb 28 06:58 PM
ROMANO KATHRYN	Officer	Feb 27 '25	Proposed Sale	175.22	750	131,415		Feb 27 11:52 AM
Krishnan Suma	President, R&D	Dec 13 '24	Sale	164.82	25,000	4,120,499	1,537,262	Dec 13 06:28 PM
Krishnan Suma	President, R&D	Dec 13 '24	Sale	164.78	25,000	4,119,524	1,475,882	Dec 13 06:28 PM
Krishnan Krish S	President and CEO	Dec 13 '24	Sale	164.82	25,000	4,120,499	1,537,262	Dec 13 06:27 PM
Krishnan Krish S	President and CEO	Dec 13 '24	Sale	164.78	25,000	4,119,524	1,475,882	Dec 13 06:27 PM
KRISH S KRISHNAN	Director	Dec 13 '24	Proposed Sale	173.40	25,000	4,335,000		Dec 13 04:22 PM
SUMA KRISHNAN	Director	Dec 13 '24	Proposed Sale	173.40	25,000	4,335,000		Dec 13 04:21 PM
Krishnan Suma	President, R&D	Sep 12 '24	Sale	197.77	25,000	4,944,237	1,562,262	Sep 13 05:45 PM
Krishnan Suma	President, R&D	Sep 12 '24	Sale	197.76	25,000	4,944,039	1,500,882	Sep 13 05:45 PM
Krishnan Krish S	President and CEO	Sep 12 '24	Sale	197.77	25,000	4,944,237	1,562,262	Sep 13 05:44 PM
Krishnan Krish S	President and CEO	Sep 12 '24	Sale	197.76	25,000	4,944,039	1,500,882	Sep 13 05:44 PM
SUMA KRISHNAN	Director	Sep 12 '24	Proposed Sale	198.79	25,000	4,969,750		Sep 12 04:33 PM
KRISH KRISHNAN	Director	Sep 12 '24	Proposed Sale	198.79	25,000	4,969,750		Sep 12 04:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KRYS

Krystal Biotech Inc

Upgrade your FINVIZ experience